Protect yourself against RSV with the Arexvy® vaccine
The RSV vaccine Arexvy® is now available at CM Mediclinic in Chiang Mai, marking a crucial step in the fight against respiratory syncytial virus (RSV). Arexvy® is approved for the active immunisation of adults aged 60 and older to prevent lower respiratory tract disease caused by RSV. This is particularly important as the virus can lead to severe health complications in older adults. Additionally, Arexvy® has also received approval from the FDA and EMA for use in adults aged 50 to 59 who are at increased risk, ensuring a broader range of protection for vulnerable populations.
CM Mediclinic is dedicated to enhancing community health through accessible vaccination programs. By offering Arexvy®, the clinic aims to educate patients about the importance of protecting themselves against RSV, especially those in higher-risk age groups. The knowledgeable medical staff at CM Mediclinic provide guidance on the vaccine's benefits and any potential side effects, ensuring that patients feel informed and confident in their healthcare choices. This proactive approach to vaccination underscores CM Mediclinic's commitment to preventing respiratory illnesses and safeguarding the health of the Chiang Mai community. Please note, the Abrysvo® RSV vaccine for expectant mothers is now available at CM Mediclinic, please contact us for details.